• Home
  • About Us
    • Team
  • Investment Approach
  • Portfolio
  • Impact
  • News & Media
  • Contact
  • Investor Relations
  • Home
  • About Us
    • Team
  • Investment Approach
  • Portfolio
  • Impact
  • News & Media
  • Contact
  • Investor Relations
•Bysomerse_wp-capital
•InNews
•Tag:Fund, Somerset
•0

Debut fund has four exits in the works: Somerset partner Ramesh Kannan

Somerset Indus Capital Partners > News > Debut fund has four exits in the works: Somerset partner Ramesh Kannan
0Shares
FundSomerset

Recent News

Crisil assigns Fund Management Grading – 1 to Somerset Indus Healthcare India Fund III – Scheme I
May 7, 2025Bysomerse_wp-capital
Somerset Bets on Medical Devices Maker “Cyrix Healthcare” In Maiden Deal from Third Fund
December 10, 2024Bysomerse_wp-capital
Impact and Sustainability Report – Somerset Indus Capital – March 2024
October 7, 2024Bysomerse_wp-capital

Tag Cloud

Apex Browndove Cygnus Cyrix Diagnostics Digital Health EICU Express Fund Genworks Globela Healthcare Delivery Hexagon Hospitals IPO Krsnaa Medical devices Medtech Nutrition Packaging Pharma Printmann Prognosys Sandor Somerset Wellness

Recent Cases

Previous PostHow remote patient monitoring is shaping the future of healthcareNext PostTHE NEXT OPPORTUNITY IN HEALTHCARE IS SPELT ‘TECHNOLOGY’

Related Posts

December 10, 2024

Somerset Bets on Medical Devices Maker “Cyrix Healthcare” In Maiden Deal from Third Fund

Bysomerse_wp-capitalInNews0
October 7, 2024

Impact and Sustainability Report – Somerset Indus Capital – March 2024

Bysomerse_wp-capitalInPublications0
February 27, 2024

Somerset Taps Local LP For Third PE Fund

Bysomerse_wp-capitalInNews0

Address

Somerset Healthcare Investment Advisors Pvt. Ltd.
401, 4th Floor, Pharma Search House,
72/73, Worli Hill Estate, Dr. B. G. Kher Road,
Worli, Mumbai 400 018

Media Centre

  • News

QUICK MENU

  • Contact Us
  • ESG & Impact
  • Investment philosophy
  • Team
  • Terms of Disclosure

Newsletter

© 2025 Somerset Healthcare Investment Advisors Pvt. Ltd. All Rights Reserved.